The COVID-19 pandemic has prompted a breakthrough in gene-based vaccines using a technology in which Evonik is a global leader ... MORE
Evonik will this month complete the consolidation of its European manufacturing activities for fabric softener ingredients to its world-class production sites ... MORE
On November 3, 2020, Evonik completed the acquisition of the Porocel Group, Houston (USA), for US$ 210 million, as planned. ... MORE
Despite the persistently challenging macroeconomic environment, Evonik continues to manage well in the crisis. ... MORE
Despite the challenging macroeconomic environment, Evonik continues to withstand the crisis well. ... MORE
Evonik is to cluster its MetAMINO® (DL-methionine) production at three international hubs (Americas, Europe, and Asia) to maximize economies of scale and utilize robust processes. ... MORE
